Metabolomics applied to maternal and perinatal health: a review of new frontiers with a translation potential
Autor(a) principal: | |
---|---|
Data de Publicação: | 2019 |
Outros Autores: | , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Clinics |
Texto Completo: | https://www.revistas.usp.br/clinics/article/view/157901 |
Resumo: | The prediction or early diagnosis of maternal complications is challenging mostly because the main conditions, such as preeclampsia, preterm birth, fetal growth restriction, and gestational diabetes mellitus, are complex syndromes with multiple underlying mechanisms related to their occurrence. Limited advances in maternal and perinatal health in recent decades with respect to preventing these disorders have led to new approaches, and “omics” sciences have emerged as a potential field to be explored. Metabolomics is the study of a set of metabolites in a given sample and can represent the metabolic functioning of a cell, tissue or organism. Metabolomics has some advantages over genomics, transcriptomics, and proteomics, as metabolites are the final result of the interactions of genes, RNAs and proteins. Considering the recent “boom” in metabolomic studies and their importance in the research agenda, we here review the topic, explaining the rationale and theory of the metabolomic approach in different areas of maternal and perinatal health research for clinical practitioners. We also demonstrate the main exploratory studies of these maternal complications, commenting on their promising findings. The potential translational application of metabolomic studies, especially for the identification of predictive biomarkers, is supported by the current findings, although they require external validation in larger datasets and with alternative methodologies. |
id |
USP-19_e22e10a35ed47001cda583e27a879f94 |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/157901 |
network_acronym_str |
USP-19 |
network_name_str |
Clinics |
repository_id_str |
|
spelling |
Metabolomics applied to maternal and perinatal health: a review of new frontiers with a translation potentialMaternal Health (MeSH)Metabolomics (MeSH);Translational Medical Research (MeSH)PredictionThe prediction or early diagnosis of maternal complications is challenging mostly because the main conditions, such as preeclampsia, preterm birth, fetal growth restriction, and gestational diabetes mellitus, are complex syndromes with multiple underlying mechanisms related to their occurrence. Limited advances in maternal and perinatal health in recent decades with respect to preventing these disorders have led to new approaches, and “omics” sciences have emerged as a potential field to be explored. Metabolomics is the study of a set of metabolites in a given sample and can represent the metabolic functioning of a cell, tissue or organism. Metabolomics has some advantages over genomics, transcriptomics, and proteomics, as metabolites are the final result of the interactions of genes, RNAs and proteins. Considering the recent “boom” in metabolomic studies and their importance in the research agenda, we here review the topic, explaining the rationale and theory of the metabolomic approach in different areas of maternal and perinatal health research for clinical practitioners. We also demonstrate the main exploratory studies of these maternal complications, commenting on their promising findings. The potential translational application of metabolomic studies, especially for the identification of predictive biomarkers, is supported by the current findings, although they require external validation in larger datasets and with alternative methodologies.Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2019-05-10info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/xmlhttps://www.revistas.usp.br/clinics/article/view/15790110.6061/clinics/2019/e894Clinics; Vol. 74 (2019); e894Clinics; v. 74 (2019); e894Clinics; Vol. 74 (2019); e8941980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/157901/153190https://www.revistas.usp.br/clinics/article/view/157901/153591Copyright (c) 2019 Clinicsinfo:eu-repo/semantics/openAccessSouza, Renato TeixeiraMayrink, JussaraLeite, Débora FariasCosta, Maria LauraCaldero, Iracema MattosRocha Filho, Edilberto AlvesVettorazzi, JaneteFeitosa, Francisco EdsonCecatti, José Guilherme2019-05-24T13:16:00Zoai:revistas.usp.br:article/157901Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2019-05-24T13:16Clinics - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Metabolomics applied to maternal and perinatal health: a review of new frontiers with a translation potential |
title |
Metabolomics applied to maternal and perinatal health: a review of new frontiers with a translation potential |
spellingShingle |
Metabolomics applied to maternal and perinatal health: a review of new frontiers with a translation potential Souza, Renato Teixeira Maternal Health (MeSH) Metabolomics (MeSH); Translational Medical Research (MeSH) Prediction |
title_short |
Metabolomics applied to maternal and perinatal health: a review of new frontiers with a translation potential |
title_full |
Metabolomics applied to maternal and perinatal health: a review of new frontiers with a translation potential |
title_fullStr |
Metabolomics applied to maternal and perinatal health: a review of new frontiers with a translation potential |
title_full_unstemmed |
Metabolomics applied to maternal and perinatal health: a review of new frontiers with a translation potential |
title_sort |
Metabolomics applied to maternal and perinatal health: a review of new frontiers with a translation potential |
author |
Souza, Renato Teixeira |
author_facet |
Souza, Renato Teixeira Mayrink, Jussara Leite, Débora Farias Costa, Maria Laura Caldero, Iracema Mattos Rocha Filho, Edilberto Alves Vettorazzi, Janete Feitosa, Francisco Edson Cecatti, José Guilherme |
author_role |
author |
author2 |
Mayrink, Jussara Leite, Débora Farias Costa, Maria Laura Caldero, Iracema Mattos Rocha Filho, Edilberto Alves Vettorazzi, Janete Feitosa, Francisco Edson Cecatti, José Guilherme |
author2_role |
author author author author author author author author |
dc.contributor.author.fl_str_mv |
Souza, Renato Teixeira Mayrink, Jussara Leite, Débora Farias Costa, Maria Laura Caldero, Iracema Mattos Rocha Filho, Edilberto Alves Vettorazzi, Janete Feitosa, Francisco Edson Cecatti, José Guilherme |
dc.subject.por.fl_str_mv |
Maternal Health (MeSH) Metabolomics (MeSH); Translational Medical Research (MeSH) Prediction |
topic |
Maternal Health (MeSH) Metabolomics (MeSH); Translational Medical Research (MeSH) Prediction |
description |
The prediction or early diagnosis of maternal complications is challenging mostly because the main conditions, such as preeclampsia, preterm birth, fetal growth restriction, and gestational diabetes mellitus, are complex syndromes with multiple underlying mechanisms related to their occurrence. Limited advances in maternal and perinatal health in recent decades with respect to preventing these disorders have led to new approaches, and “omics” sciences have emerged as a potential field to be explored. Metabolomics is the study of a set of metabolites in a given sample and can represent the metabolic functioning of a cell, tissue or organism. Metabolomics has some advantages over genomics, transcriptomics, and proteomics, as metabolites are the final result of the interactions of genes, RNAs and proteins. Considering the recent “boom” in metabolomic studies and their importance in the research agenda, we here review the topic, explaining the rationale and theory of the metabolomic approach in different areas of maternal and perinatal health research for clinical practitioners. We also demonstrate the main exploratory studies of these maternal complications, commenting on their promising findings. The potential translational application of metabolomic studies, especially for the identification of predictive biomarkers, is supported by the current findings, although they require external validation in larger datasets and with alternative methodologies. |
publishDate |
2019 |
dc.date.none.fl_str_mv |
2019-05-10 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/clinics/article/view/157901 10.6061/clinics/2019/e894 |
url |
https://www.revistas.usp.br/clinics/article/view/157901 |
identifier_str_mv |
10.6061/clinics/2019/e894 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/clinics/article/view/157901/153190 https://www.revistas.usp.br/clinics/article/view/157901/153591 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2019 Clinics info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2019 Clinics |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/xml |
dc.publisher.none.fl_str_mv |
Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo |
publisher.none.fl_str_mv |
Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo |
dc.source.none.fl_str_mv |
Clinics; Vol. 74 (2019); e894 Clinics; v. 74 (2019); e894 Clinics; Vol. 74 (2019); e894 1980-5322 1807-5932 reponame:Clinics instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Clinics |
collection |
Clinics |
repository.name.fl_str_mv |
Clinics - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
||clinics@hc.fm.usp.br |
_version_ |
1800222764112543744 |